Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority claimed from PCT/US2017/053880external-prioritypatent/WO2018064255A2/en
Publication of EA201990824A1publicationCriticalpatent/EA201990824A1/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Данное раскрытие относится, в целом, к человеческим антителам против интерлейкина-2 человека (ИЛ-2) и способам применения таких антител для модуляции активности ИЛ-2 и применения при лечении состояний, таких как онкологические заболевания, аутоиммунные заболевания или инфекции.This disclosure relates generally to human antibodies against human interleukin-2 (IL-2) and methods for using such antibodies to modulate IL-2 activity and use in the treatment of conditions such as cancer, autoimmune diseases or infections.
EA201990824A2016-11-112017-09-28
ANTIBODIES THAT CONTACT INTERLEUKIN-2 AND THEIR APPLICATION
EA201990824A1
(en)